Evidence map›Paper›PMID 32222895›Full record

ArticleNeurogenetics2020

Autosomal dominant hereditary spastic paraplegia caused by mutation of UBAP1.

Jianda Wang, Yanqi Hou, Lina Qi, Shuang Zhai, Liangwu Zheng, Lin Han, Yufan Guo, Bijun Zhang, Pu Miao, Yuting Lou and 5 more

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Neurogenetics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.7field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. A novel mutation in theFrontiers in genetics · 2022
    Article
  6. Novel Frameshift Heterozygous Mutation inFrontiers in neurology · 2022
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 1 country.

Jianda WangDepartment of Pediatrics, The Second Affiliated Hospital of Zhejiang University School of Medicine, No.88 Jiefang Road, Hangzhou, 310009, Zhejiang Province, China.
Yanqi HouRunningGene Inc., Beijing, 100083, China.
Lina QiDepartment of Pediatrics, Yuhang Branch of The Second Affiliated Hospital of Zhejiang University, Hangzhou, 330110, Zhejiang Province, China.
Shuang ZhaiThe Children's Hospital, Zhejiang University School of Medicine, Hangzhou, 310052, Zhejiang Province, China.
Liangwu ZhengThe People's Hospital of Jiangshan, Jiangshan, 324100, Zhejiang Province, China.
Lin HanRunningGene Inc., Beijing, 100083, China.
Yufan GuoDepartment of Pediatrics, The Second Affiliated Hospital of Zhejiang University School of Medicine, No.88 Jiefang Road, Hangzhou, 310009, Zhejiang Province, China.
Bijun ZhangDepartment of Pediatrics, The Second Affiliated Hospital of Zhejiang University School of Medicine, No.88 Jiefang Road, Hangzhou, 310009, Zhejiang Province, China.
Pu MiaoDepartment of Pediatrics, The Second Affiliated Hospital of Zhejiang University School of Medicine, No.88 Jiefang Road, Hangzhou, 310009, Zhejiang Province, China.
Yuting LouDepartment of Pediatrics, The Second Affiliated Hospital of Zhejiang University School of Medicine, No.88 Jiefang Road, Hangzhou, 310009, Zhejiang Province, China.
Xiaoxiao XuDepartment of Pediatrics, The Second Affiliated Hospital of Zhejiang University School of Medicine, No.88 Jiefang Road, Hangzhou, 310009, Zhejiang Province, China.
Ye WangDepartment of Pediatrics, The Second Affiliated Hospital of Zhejiang University School of Medicine, No.88 Jiefang Road, Hangzhou, 310009, Zhejiang Province, China.
Yanqi RenRunningGene Inc., Beijing, 100083, China.
Zhenhua CaoRunningGene Inc., Beijing, 100083, China.
Jianhua FengDepartment of Pediatrics, The Second Affiliated Hospital of Zhejiang University School of Medicine, No.88 Jiefang Road, Hangzhou, 310009, Zhejiang Province, China. hzhz87083886@zju.edu.cn.
Second Affiliated Hospital of Zhejiang University · CNChildren's Hospital of Zhejiang University · CNPeople's Hospital of Bishan District · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hereditary spastic paraplegias (HSP) are a group of rare neurodegenerative diseases characterized by progressive spastic paraparesis. UBAP1 was recently found to induce a rare type of HSP (SPG80). We identified a family with eight inherited spastic paraplegic patients carrying a novel heterozygous mutation c.279delG (p.S94Vfs*9) of UBAP1. We demonstrated a lack of functional UBAP1 in these patients, resulting in the neurological disorder caused by interceptions of the ESCRT pathway. Extending from the older onset-age identified from this family, we found that comparing with the European and other populations, Asian patients displayed less proportion of severe patients and an older average age at onset. The origins of SPG80 patients associated with both their onset age and their disease severity, while the age at onset was not correlated with the disease severity.

Indexed as

Genes, DominantMutationAdolescentAge of OnsetCarrier ProteinsFamily HealthFrameshift MutationGenetic VariationHeterozygoteHumansMalePedigreeSequence Analysis, DNASpastic Paraplegia, HereditaryCarrier ProteinsUBAP1 protein, humanHereditary spastic paraplegiasHSPSPG80UBAP1

Identifiers

PMID32222895
OpenAlexW3013421688

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.